<DOC>
	<DOCNO>NCT01223924</DOCNO>
	<brief_summary>This randomized double-blinded placebo-controlled，single-dose escalation trial healthy volunteer .</brief_summary>
	<brief_title>Single-dose Escalation Trial M2ES Healthy Volunteer</brief_title>
	<detailed_description>Randomized double-blinded placebo-controlled，single-dose escalation trial health volunteer , determine safety max tolerate dose health volunteer .</detailed_description>
	<criteria>1 . Physical mental healthy basis medical evaluation reveals absence clinically relevant abnormality include physical examination , medical history , electrocardiogram ( ECG ) , vital sign , result blood biochemistry , blood coagulation hematology test urinalysis carry screen . 2 . 19 45 year age . 3 . Body mass index ( 1925 kg/m2 ) , body weight ≥55kg male subject , ≥45kg female . 4 . Negative pregnant test , menstrual period female . 5. willing comply protocol . 1 . Be allergic endostatin 2 . Have take drug last 2 week 3 . Have Participated clinical trail last 2 week 4 . Cardiovasculre , respiratory , Liver , renal , gastrointestinal hematologic endocrine mental disease 5 . HIV1 infect 6 . HBV , HBV infect , Hepatitis B surface antigen positive</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>cancer</keyword>
</DOC>